cetuximab

Trials studying cetuximab

• phase1A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)recruitingn=830
• phase2A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Canceractive not recruitingn=108
• phase1A Study of ASP3082 in Adults With Advanced Solid Tumorsrecruitingn=681
• phase2KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)recruitingn=140
• phase2A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studiesrecruitingn=170
• phase3Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)active not recruitingn=461
• phase1A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumorsrecruitingn=570
• phase1A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Aloneactive not recruitingn=91